A pilot study of the safety and efficacy of thymosin α(1) in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy

To study the safety and efficacy of thymosin α(1) in stimulating immune reconstitution in combination with highly active antiretroviral therarpy (HAART), a phase II randomized, controlled open-label trial of subcutaneous thymosin α(1) was undertaken for 12 weeks. Twenty clinically stable patients wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: CHADWICK, D, PIDO-LOPEZ, J, PIRES, A, IMAMI, N, GOTCH, F, VILLACIAN, J S, RAVINDRAN, S, PATON, N I
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2003
Assuntos:
Clinical Studies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1808897/
https://ncbi.nlm.nih.gov/pubmed/14632754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2003.02331.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados